FDA approved high-dose inactivated influenza vaccine for people ages 65 years and older
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
On Dec. 18, 2009, the MUSC and the South Carolina Research Authority opened the Innovation Center in Charleston….
On Dec. 3, 2009, the Thai HIV vaccine clinical trial results were published in the New England Journal…
On Nov. 11, 2009, the Pacific Northwest Diabetes Research Institute announced the appointment of William Hagopian, M.D., Ph.D.,…
On Nov. 16, 2009, the U.S. Centers for Disease Control and Prevention (CDC) recommended a single dose of…
On Nov. 12, 2009, the Global Coalition against Child Pneumonia was established to raise awareness about the toll…
On Nov. 9, 2009, The Global Cassava Partnership (GCP-21) — a team of academic, government and industry researchers…
On Nov. 2, 2009, an international consortium lead by Larry Schook at the University of Illinois in Champaign…
On Nov. 2, 2009 Sanford Health merged with MeritCare. In 2007 the Sioux Valley Health Care System was…
On Nov. 1, 2009, an international consortium lead by Chinese and U.S. institutions announced they had sequenced the…
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with MarÃa Rosa Menocal, a Yale…
On Oct. 24, 2009, President Barack Obama declared the swine flu (N1n1) outbreak a national emergency. The declaration…
On Oct. 21, 2009, Merck announced that the company will not resume production of monovalent measles, mumps, and…
On Oct. 20, 2009, AGA Medical, based in Plymouth, designed and sold small devices that closed defects in…
On Oct. 16, 2009, the U.S. Food and Drug Administration (FDA) approved new indication for gardasil to prevent…
On Oct. 16, 2009, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Cervarix [Human papillomavirus…
On Oct. 13, 2009, environmentalist and former genetics professor David Suzuki received the Right Livelihood Award for his…
On Oct. 8, 2009, Omeros Corp. launched an initial public offering at $10.00 per share and raised $62.1…
On Oct. 7, 2009, the Nobel Foundation announced that Ada E. Yonath had won a share of the…
On Oct. 7, 2009, Francis S. Collins, M.D., Ph.D. was appointed the 16th Director of the National Institutes…
On Oct. 5, 2009, Carol W. Greider won a share of the Nobel Prize in Physiology or Medicine…
On Oct. 5, 2009, Elizabeth H. Blackburn won a share of the Nobel Prize in Physiology or Medicine…
On Sept. 27, 2009, University of Toronto researchers announced that they had used nanomaterials to develop a microchip…
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
On Sept. 16, 2009, Brian J. Druker, M.D.,whose research led to the development of Gleevec, the first targeted…
On Sept. 15, 2009, the U.S. Food and Drug Administration (FDA) approved four Influenza A (H1N1) 2009 Monovalent…
In Sept. 2009, Seattle Cancer Care Alliance (SCCA) House opened. A state-of-the-art, 80-room, ‘green building,’ SCCA House offers…
On Sept. 1, 2009, Confirma was acquired by Milwaukee, WI-based Merge Healthcare in an all-stock transaction valued at…
On Jul. 31, 2009, the Immunization Practices Advisory Committee (ACIP) updates the 2008 recommendations regarding the use of…
On Jul. 15, 2009, Pfizer with the Ontario Institute for Cancer Research (OICR) and the Ontario Cancer Institute…